Department of Rehabilitation Medicine, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Department of Rehabilitation Medicine, Yokohama City University Medical Center, Yokohama, Japan.
Nutrition. 2019 May;61:111-118. doi: 10.1016/j.nut.2018.11.005. Epub 2018 Nov 22.
The aim of this study was to evaluate the effect of sarcopenia on functional outcomes, including activities of daily living (ADLs); dysphagia status; and the rate of home discharge, among hospitalized adults receiving convalescent rehabilitation.
A retrospective cohort study was conducted with 898 patients newly admitted to in-hospital convalescent rehabilitation wards at a single rehabilitation hospital in Japan. Baseline sarcopenia was diagnosed using muscle mass index and handgrip strength according to the criteria of the European Working Group on Sarcopenia in Older People, with the cutoff values of the Asian Working Group for Sarcopenia. The primary outcome was ADLs, assessed by Functional Independence Measure motor (FIM-motor) score at hospital discharge. The secondary outcomes included dysphagia, assessed by the Food Intake Level Scale (FILS), at discharge, and the rate of home discharge. Three multivariate analyses revealed an association between sarcopenia and the clinical outcomes. Each analysis adjusted for the following confounders: age, sex, time from onset, premorbid ADLs, comorbidities, cognitive level, nutritional status, major drugs, and admission diagnoses.
After enrollment, 795 patients (mean age 74.9 ± 13.2 y; 59% women) were included in the final analysis. Admission diagnoses included stroke (n = 276; 34.7%), musculoskeletal disorders (n = 382; 48.1%), and hospital-associated deconditioning (n = 137; 17.2%). Of the 795 patients examined, 402 (50.6%) had sarcopenia. The multiple linear regression analysis showed that sarcopenia was independently associated with FIM motor score at discharge in patients with all disease types (β = -0.189 [stroke], -0.240 [musculoskeletal disorders], -0.230 [hospital-associated deconditioning]; all P < 0.05), with FILS score at discharge only in patients with musculoskeletal disorders (β = -0.271, P < 0.001), but not in patients with stroke (β = -0.061, P = 0.375) or those with hospital-associated deconditioning (β = -0.131, P = 0.070). The multiple logistic regression analysis showed that sarcopenia was associated with rate of home discharge in all disease types (odds ratio [OR], 0.201; 95% confidence interval [CI], 0.067-0.597 for stroke; OR, 0.242; 95% CI, 0.076-0.772 for musculoskeletal disorders; OR, 0.121; 95% CI, 0.110-0.347 for hospital-associated deconditioning; all P < 0.05).
Sarcopenia is associated with worse recovery of ADLs and dysphagia and a lower rate of home discharge in hospitalized adults undergoing convalescent rehabilitation. Early detection of sarcopenia and treatment by rehabilitation nutrition should be implemented in this population.
本研究旨在评估肌少症对功能结局的影响,包括住院接受康復疗养的成年人的日常生活活动(ADL);吞咽状况;以及出院回家的比率。
本研究采用回顾性队列研究,纳入了日本一家康复医院新入院的 898 名住院康復疗养病房的患者。根据欧洲老年人肌少症工作组的标准,使用肌肉质量指数和握力来诊断基线肌少症,亚洲肌少症工作组的截值。主要结局是出院时功能独立性测量运动(FIM-motor)评分评估的 ADL。次要结局包括出院时通过饮食摄入水平量表(FILS)评估的吞咽情况,以及出院回家的比率。三项多变量分析揭示了肌少症与临床结局之间的关联。每项分析均调整了以下混杂因素:年龄、性别、发病时间、发病前 ADL、合并症、认知水平、营养状况、主要药物和入院诊断。
入组后,795 名患者(平均年龄 74.9±13.2 岁;59%为女性)纳入最终分析。入院诊断包括中风(n=276;34.7%)、肌肉骨骼疾病(n=382;48.1%)和医院相关的身体机能下降(n=137;17.2%)。在 795 名接受检查的患者中,402 名(50.6%)患有肌少症。多元线性回归分析显示,肌少症与所有疾病类型患者出院时的 FIM 运动评分独立相关(β= -0.189 [中风],-0.240 [肌肉骨骼疾病],-0.230 [医院相关的身体机能下降];均 P<0.05),仅与肌肉骨骼疾病患者的 FILS 评分相关(β= -0.271,P<0.001),而与中风患者(β= -0.061,P=0.375)或医院相关的身体机能下降患者(β= -0.131,P=0.070)无关。多元逻辑回归分析显示,肌少症与所有疾病类型的出院回家比率相关(优势比[OR],0.201;95%置信区间[CI],0.067-0.597 为中风;OR,0.242;95% CI,0.076-0.772 为肌肉骨骼疾病;OR,0.121;95% CI,0.110-0.347 为医院相关的身体机能下降;均 P<0.05)。
肌少症与住院接受康復疗养的成年人 ADL 恢复较差、吞咽困难和出院回家比率较低有关。应在该人群中早期发现肌少症并通过康復营养进行治疗。